Shiona M. Laing

SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase

David J. Keeling, Shiona M. Laing, Jörg Senn‐Bilfinger · Biochemical Pharmacology · 1988 · 69 citations

Signal Transduction, Molecular Physiology, Biochemistry +9

Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogs of 4-(arylamino)quinolines

Thomas H. Brown, Robert J. Ife, David J. Keeling et al. · Journal of Medicinal Chemistry · 1990 · 58 citations · Full text

Medicinal Chemistry, Target Enzyme, Quinoline 4 +12

Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent

Colin A. Leach, Thomas H. Brown, R J Ife et al. · Journal of Medicinal Chemistry · 1992 · 56 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Pentagastrin-stimulated Rat +13

By 1023/SK&F 96022: Biochemistry of a novel (H+ + K+-ATPase inhibitor

Wolfgang Simon, David J. Keeling, Shiona M. Laing et al. · Biochemical Pharmacology · 1990 · 53 citations

Molecular Pharmacology, Aldo-keto Reductase, Cellular Enzymology +9

SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase

David J. Keeling, R.C. Malcolm, Shiona M. Laing et al. · Biochemical Pharmacology · 1991 · 50 citations

Molecular Physiology, Biochemistry, Medicine +7